Activin and Inhibin

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In VitroFTI-2153,

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 TFA is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 TFA is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 TFA is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 TFA is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 TFA is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 TFA is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In

FTO-IN-1 TFA is a fat mass and obesity-associated enzyme (FTO) inhibitor extracted from patent WO2018157843A1, compound 32, with an IC 50 of &lt:1 μM. FTO-IN-1 TFA can be used for the research of cancer.Appearance:SolidIC50&amp: Target:IC50: &lt:1

FTO-IN-1 TFA is a fat mass and obesity-associated enzyme (FTO) inhibitor extracted from patent WO2018157843A1, compound 32, with an IC 50 of &lt:1 μM. FTO-IN-1 TFA can be used for the research of cancer.Appearance:SolidIC50&amp: Target:IC50: &lt:1

FTO-IN-1 TFA is a fat mass and obesity-associated enzyme (FTO) inhibitor extracted from patent WO2018157843A1, compound 32, with an IC 50 of &lt:1 μM. FTO-IN-1 TFA can be used for the research of cancer.Appearance:SolidIC50&amp: Target:IC50: &lt:1

FTO-IN-8 (FTO-43) is a N6-methyladenosine demethylase ( FTO ) (fat mass- and obesity-associated protein) inhibitor with the IC 50 value of 5.5 μM. FTO-IN-8 has anti-cancer cell proliferative activity.In VitroFTO-IN-8 (FTO-43) (0-50 μM, 24-72 h)

FTO-IN-8 (FTO-43) is a N6-methyladenosine demethylase ( FTO ) (fat mass- and obesity-associated protein) inhibitor with the IC 50 value of 5.5 μM. FTO-IN-8 has anti-cancer cell proliferative activity.In VitroFTO-IN-8 (FTO-43) (0-50 μM, 24-72 h)